How has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...
Read moreThe SMC has recently announced that it is beginning to restart its medicines appraisal process in a ...
Read moreNICE has decided to adapt the technical engagement step in a hope to improve stakeholder inclusion, ...
Read moreWithout a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...
Read moreWe received fabulous feedback, with responses from at least 15 industry executives across global pha...
Read moreWhilst many businesses are currently working remotely, up-skilling your workforce through interactiv...
Read moreCAR T-cell therapies and speculation in the pricing and market access implications for the lymphoma ...
Read moreArrangements made between manufacturers and payers which are being implemented for innovative treatm...
Read moreGiven the shutdown occurring in response to COVID-19, payers and HTA bodies are struggling to adjust...
Read more"Payer" generally refers to people or bodies other than the patient that finance or refund the cost ...
Read more